Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 18, 2021
0
Date of Patent
May 14, 2024
0
Patent Application Number
17178926
0
Patent Citations
‌
US Patent 10308696 IL2 and TNF immunoconjugates
0
‌
US Patent 10350266 Method of treating cancer with a multiple integrin binding Fc fusion protein
0
‌
US Patent 10350304 Nucleic acid products and methods of administration thereof
0
‌
US Patent 10358477 IL-15Ralpha sushi domain—IL-15 fusion proteins
0
‌
US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 10363321 Nucleic acid products and methods of administration thereof
0
‌
US Patent 10376564 Interleukin-2 for treating food allergy
0
‌
US Patent 10428145 PD-1 binding proteins and methods of use thereof
0
‌
US Patent 10493148 PD-1 agonist antibodies and uses thereof
0
‌
US Patent 10676516 Targeted immunotolerance
0
•••
Patent Inventor Names
Joanne L. Viney
0
Kevin Lewis Otipoby
0
Susmita Borthakur
0
Daniel Rios
0
Salvatore Alioto
0
Lindsay J. Edwards
0
Purvi Mande
0
Nathan Higginson-Scott
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11981715
0
Patent Primary Examiner
‌
Ruixiang Li
0

Find more entities like US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo